Domestic marketing and medical insurance status of tucatinib

Tucatinib, also known as tucatinib, is an important treatment that combines with trastuzumab and capecitabine to provide a new treatment option for patients with metastaticHER2-positive breast cancer (especially those whose cancer has spread to the brain) or breast cancer that remains unresectable after multiple anti-HER2 treatments. At the same time, the combination therapy of tucatinib and trastuzumab is also suitable for the treatment of RAS wild-type HER2-positive colorectal cancer that has spread or cannot be surgically removed. This treatment is suitable for patients who have not responded well to other cancer treatments, such as fluoropyrimidine, oxaliplatin, and irinotecan. Before using this drug, doctors will perform special tests to confirm whether specific genetic mutations are present.

Regarding tucatinib dosing instructions, the recommended dose is 300 mg orally twice daily. It can be taken with a meal or alone. For patients with severe hepatic impairment, the recommended dose is 200 mg twice daily.

Although tucatinib brings new treatment hope to many patients, it can also cause side effects such as diarrhea, burning or tingling sensations in the hands and feet, nausea, fatigue, liver damage, vomiting, inflammation of the mouth and lips, decreased appetite, abdominal pain, headache, anemia, and rash. Also, pregnant or breastfeeding women should use this medication with special caution because it may cause harm to a developing fetus or infant.

Unfortunately, tucatinib has not yet received marketing approval in China, so it cannot be included in the reimbursement scope of medical insurance. For patients who need this drug, purchasing the original drug overseas may be an option, but the price is relatively high. For example, a box of 60 150 mg tucatinib is priced as high as 72,000 yuan in overseas markets.

Fortunately, there are some more affordable generic drugs on the market for patients to choose from. For example, a box of 30 150mg medicines produced by Everest Pharmaceuticals in Bangladesh is priced at 6,000 yuan, while products of the same specification produced by Zisika Pharmaceuticals in Bangladesh are more affordable at 4,500 yuan per box. In addition, generic drugs from Lucius Pharmaceuticals in Laos also provide good value for money. The price of 30 pills of 150mg is about 3,600 yuan.

For more questions or information about tucatinib, patients are advised to consult a professional overseas medical consulting agency to ensure accurate and timely information.